首页> 外文期刊>Current molecular imaging >PET-MRI Based Molecular Imaging as a Response Marker in Cervical Cancer: A Systematic Review
【24h】

PET-MRI Based Molecular Imaging as a Response Marker in Cervical Cancer: A Systematic Review

机译:基于PET-MRI的分子成像作为宫颈癌反应的标志物:系统评价

获取原文
获取原文并翻译 | 示例
           

摘要

Therapeutic strategies continue to evolve for treatment of women with cervical cancer. However there is dearth of validated biomarkers of therapeutic response and overall survival. In recent years development of molecular imaging techniques using Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) has allowed evaluation of imaging biomarkers of proliferation, angiogenesis, perfusion and hypoxia as prognostic imaging biomarkers. The present systematic review summarizes the current role of multifunctional PET and MRI as a response biomarker for cervical cancer.
机译:治疗策略继续发展以治疗患有宫颈癌的妇女。然而,缺乏有效的治疗反应和整体生存的生物标志物。近年来,使用磁共振成像(MRI)和正电子发射断层扫描(PET)进行的分子成像技术的发展已允许评估增殖,血管生成,灌注和缺氧的成像生物标记物作为预后成像生物标记物。本系统综述总结了多功能PET和MRI作为宫颈癌反应生物标志物的当前作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号